FeesSafety
Pluang+

Eupraxia Pharmaceuticals launches $125M at-the-market equity program but plans no immediate sales.

Company Fundamentals
10 Nov 2026, 23:16 WIB
GlobeNewsWire
View Source
Neutral
Eupraxia Pharmaceuticals launches $125M at-the-market equity program but plans no immediate sales.

Eupraxia Pharmaceuticals has established an at-the-market (ATM) equity offering program allowing it to sell up to $125 million of common shares. The company states this is a routine corporate measure and has no current plans to use the program soon, as its cash runway extends through the second half of 2028. Shares under the program would be sold at market prices via agents in Canada and the U.S. This move provides Eupraxia with financial flexibility for future needs while maintaining current operational funding.

Eupraxia Pharmaceuticals' ATM offering program is presented here with a snapshot of the Health sector on Pluang. As of Nov 11, 2026 04:02 WIB, 52 of 150 priced Health-sector US stocks rose while 97 fell. Notable movers include BNGO at USD 1.25 with a 7.76% increase and 100% buy order activity, CTXR at USD 0.49 down 7.51%, and LQDA at USD 51.44 up 7.46%.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
1 hour ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
1 hour ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
1 hour ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
3 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App